Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BVS NASDAQ:EYE NYSE:INSP NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$6.94-0.3%$7.01$5.81▼$14.38$573.79M0.81376,745 shs148,039 shsEYENational Vision$25.47-0.5%$25.52$9.75▼$29.59$2.02B1.31.72 million shs1.32 million shsINSPInspire Medical Systems$77.45-3.4%$82.44$70.77▼$216.01$2.29B1.16907,222 shs1.84 million shsWRBYWarby Parker$21.26-4.1%$25.61$13.63▼$29.73$2.24B2.11.64 million shs2.23 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus-0.29%+4.20%+0.73%+5.63%-47.78%EYENational Vision-0.55%-1.32%-10.25%+1.80%+159.90%INSPInspire Medical Systems-3.32%-0.75%-0.49%-39.98%-59.75%WRBYWarby Parker-4.19%-2.11%-24.60%-12.84%+21.94%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$6.94-0.3%$7.01$5.81▼$14.38$573.79M0.81376,745 shs148,039 shsEYENational Vision$25.47-0.5%$25.52$9.75▼$29.59$2.02B1.31.72 million shs1.32 million shsINSPInspire Medical Systems$77.45-3.4%$82.44$70.77▼$216.01$2.29B1.16907,222 shs1.84 million shsWRBYWarby Parker$21.26-4.1%$25.61$13.63▼$29.73$2.24B2.11.64 million shs2.23 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus-0.29%+4.20%+0.73%+5.63%-47.78%EYENational Vision-0.55%-1.32%-10.25%+1.80%+159.90%INSPInspire Medical Systems-3.32%-0.75%-0.49%-39.98%-59.75%WRBYWarby Parker-4.19%-2.11%-24.60%-12.84%+21.94%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBVSBioventus 2.75Moderate Buy$13.7598.13% UpsideEYENational Vision 2.45Hold$24.73-2.92% DownsideINSPInspire Medical Systems 2.38Hold$141.1382.24% UpsideWRBYWarby Parker 2.45Hold$25.2018.56% UpsideCurrent Analyst Ratings BreakdownLatest BVS, INSP, WRBY, and EYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/25/2025EYENational VisionWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/25/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/24/2025INSPInspire Medical SystemsStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$100.0010/24/2025INSPInspire Medical SystemsJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Hold$160.00 ➝ $85.0010/24/2025WRBYWarby ParkerWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/15/2025INSPInspire Medical SystemsTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$125.00 ➝ $90.0010/10/2025INSPInspire Medical SystemsRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$150.0010/8/2025EYENational VisionWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025WRBYWarby ParkerWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025INSPInspire Medical SystemsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$150.00 ➝ $125.00(Data available from 10/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBVSBioventus$564.14M1.02$0.55 per share12.58$2.80 per share2.48EYENational Vision$1.82B1.11$1.64 per share15.57$10.37 per share2.46INSPInspire Medical Systems$802.80M2.85$1.71 per share45.37$23.01 per share3.37WRBYWarby Parker$821.35M2.72$0.34 per share62.62$3.35 per share6.34Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBVSBioventus-$156.23MN/AN/A15.09N/A-7.11%15.61%4.01%N/AEYENational Vision-$28.50M-$0.18N/A94.332.82-0.75%3.56%1.49%11/5/2025 (Estimated)INSPInspire Medical Systems$53.51M$1.7344.7724.052.426.17%10.38%8.93%11/3/2025 (Estimated)WRBYWarby Parker-$20.39M-$0.07N/A212.55N/A-1.12%-0.79%-0.41%11/6/2025 (Estimated)Latest BVS, INSP, WRBY, and EYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025WRBYWarby Parker$0.09N/AN/AN/A$224.49 millionN/A11/5/2025Q3 2025EYENational Vision$0.12N/AN/AN/A$472.98 millionN/A11/3/2025Q3 2025INSPInspire Medical Systems-$0.11N/AN/AN/A$220.39 millionN/A8/6/2025Q2 2025EYENational Vision$0.12$0.18+$0.06$0.11$469.21 million$486.42 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBVSBioventusN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/AINSPInspire Medical SystemsN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBVSBioventus1.851.410.99EYENational Vision0.300.520.31INSPInspire Medical SystemsN/A6.144.84WRBYWarby ParkerN/A2.552.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBVSBioventus62.94%EYENational VisionN/AINSPInspire Medical Systems94.91%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipBVSBioventus33.00%EYENational Vision2.70%INSPInspire Medical Systems4.10%WRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBVSBioventus1,20082.68 million54.46 millionNot OptionableEYENational Vision13,41179.20 million77.06 millionOptionableINSPInspire Medical Systems1,24629.57 million28.36 millionOptionableWRBYWarby Parker3,780105.19 million86.00 millionOptionableBVS, INSP, WRBY, and EYE HeadlinesRecent News About These CompaniesWeiss Ratings Reaffirms "Sell (D-)" Rating for Warby Parker (NYSE:WRBY)October 25 at 1:23 PM | marketbeat.comWarby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025October 16, 2025 | theglobeandmail.comWarby Parker Inc. (NYSE:WRBY) Given Consensus Rating of "Hold" by BrokeragesOctober 14, 2025 | marketbeat.comEstimating The Intrinsic Value Of Warby Parker Inc. (NYSE:WRBY)October 8, 2025 | finance.yahoo.comWarby Parker (NYSE:WRBY) Receives Sell (D-) Rating from Weiss RatingsOctober 8, 2025 | marketbeat.comGoldman Sachs Maintains Warby Parker (WRBY) Buy RecommendationOctober 7, 2025 | msn.com18,527 Shares in Warby Parker Inc. $WRBY Bought by Wealth Enhancement Advisory Services LLCOctober 7, 2025 | marketbeat.comDeep Dive Into Warby Parker Stock: Analyst Perspectives (8 Ratings)October 6, 2025 | benzinga.comWarby Parker: Excellent Management Of Tariffs, Accelerating GrowthOctober 6, 2025 | seekingalpha.comThe Goldman Sachs Group Issues Positive Forecast for Warby Parker (NYSE:WRBY) Stock PriceOctober 6, 2025 | marketbeat.comVaughan Nelson Investment Management L.P. Buys 1,137,970 Shares of Warby Parker Inc. $WRBYOctober 4, 2025 | marketbeat.comWarby Parker Is Still Worth Buying At This PriceSeptember 26, 2025 | seekingalpha.comWarby Parker (NYSE:WRBY) CEO Neil Harris Blumenthal Sells 500 SharesSeptember 20, 2025 | insidertrades.comInsider Selling: Warby Parker (NYSE:WRBY) CEO Sells 41,084 Shares of StockSeptember 16, 2025 | insidertrades.comWarby Parker (WRBY) Rose Following the Partnership Announcement with GoogleSeptember 11, 2025 | insidermonkey.comJoel Cutler Sells 35,000 Shares of Warby Parker (NYSE:WRBY) StockSeptember 11, 2025 | insidertrades.comEvercore ISI Reaffirms Their Hold Rating on Warby Parker (WRBY)September 9, 2025 | theglobeandmail.comWarby Parker Inc. (WRBY) Presents At Goldman Sachs 32nd Annual Global Retailing Conference 2025 TranscriptSeptember 4, 2025 | seekingalpha.comWarby Parker Announces Participation in the Goldman Sachs 32nd Annual Global Retailing ConferenceAugust 28, 2025 | businesswire.comWarby Parker Teams Up with Arch Manning for Three-Year PartnershipAugust 27, 2025 | finance.yahoo.comStocks Showing Market Leadership: Warby Parker Earns 93 RS RatingAugust 14, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBVS, INSP, WRBY, and EYE Company DescriptionsBioventus NYSE:BVS$6.94 -0.02 (-0.29%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$6.76 -0.18 (-2.52%) As of 10/24/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.National Vision NASDAQ:EYE$25.47 -0.14 (-0.55%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$24.67 -0.80 (-3.14%) As of 10/24/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Inspire Medical Systems NYSE:INSP$77.44 -2.73 (-3.40%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$78.55 +1.11 (+1.43%) As of 10/24/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Warby Parker NYSE:WRBY$21.26 -0.91 (-4.08%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$21.26 +0.00 (+0.02%) As of 10/24/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 10/20 - 10/24 Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tractor Supply Stock Looks Like a Buy-and-Hold Winner Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Fal.Con Europe Could Be CrowdStrike’s Early Earnings Catalyst Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
